Blog Archives

Batista

Jan 14

Batista

B cells are important immune cells. They produce antibodies against foreign molecules on pathogens, and in this way they protect us against disease.   In our laboratory, we are interested in both the cellular and the molecular events that lead to the activation of B cells. We want to understand how these events affect the […]

Read more
Allen

Apr 26

Allen

The Allen laboratory is primarily investigating the impact that viral sequence diversity has on immune control in the setting of HIV-1 infection. Cellular CD8+ T cell responses (CTL) represent a critical arm of the immune response in the control of HIV-1 infections. The ability of HIV to rapidly evolve and escape from these responses within […]

Read more
Pillai

Mar 02

Pillai

Shiv Pillai MD, PhD is a Professor of Medicine and Health Sciences and Technology at Harvard Medical School. He is the Program Director of an NIH Funded Autoimmune Center of Excellence at Massachusetts General Hospital and the Director of the Masters in Medical Sciences in Immunology Program at Harvard Medical School.   Dr. Pillai coined […]

Read more
Lingwood

Apr 29

Lingwood

Daniel Lingwood was born and raised in Toronto, Canada. He studied physiology at the University of Guelph (BSc) and completed his MSc examining the role of membrane lipids in regulating ion transport ATPases. His subsequent doctoral work at the Max Planck Institute for Molecular Biology and Genetics in Dresden, Germany, helped to define the Lipid Raft […]

Read more
Balazs

Apr 15

Balazs

Alejandro Balazs received his undergraduate degree at the University of California at Los Angeles and his PhD from Harvard University and is currently an Assistant Professor in medicine at Harvard Medical School.   During his postdoctoral training at the California Institute of Technology, he developed Vectored ImmunoProphylaxis (VIP) as a means of engineering humoral immunity, […]

Read more
Juelg

Sep 18

Juelg

Dr. Juelg is interested in applying new technologies to decipher the complex and heterogeneous CD8+ T-cell responses induced by vaccination while comparing it to natural HIV infection. In collaboration with Dr. Chris Love at the Massachusetts Institute of Technology he has developed a platform for the high-throughput analysis of single cytotoxic T-cells. Using this and […]

Read more
Ndhlovu

Apr 09

Ndhlovu

Dr. Zaza Ndhlovu’s studies seek to understand the mechanism by which rare people who are able to control viral replication in the absence of therapy (elite controllers) achieve long-term asymp¬tomatic infection. Dr. Ndhlovu and his colleagues have made significant discoveries about key features of HIV-specific killer T lymphocyte subsets that are able to inhibit viral […]

Read more
Barouch

Jan 31

Barouch

Dr. Dan Barouch received his Ph.D. in immunology from Oxford University and his M.D. from Harvard Medical School.  He is currently Professor of Medicine at Harvard Medical School and Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center.  He is a key part of the Bill & Melinda Gates […]

Read more
Chakraborty

Jan 31

Chakraborty

Arup K. Chakraborty is the Robert T. Haslam Professor of Chemical Engineering, Physics, Chemistry, and Biological Engineering at MIT.  He is the founding Director of MIT’s Institute for Medical Engineering and Science.  He is also a founding steering committee member of the Ragon Institute of MIT, MGH, and Harvard, and an Associate Member of the […]

Read more
Burton

Jan 31

Burton

Dennis Burton is Professor of Immunology and Microbiology at the Scripps Research Institute in La Jolla, California; Member of the Steering Committee of the Ragon Institute of MGH, MIT and Harvard; Scientific Director of the Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative and Director of the NIH Center for HIV/AIDS Vaccine Immunology and […]

Read more